DSSNYSEPaperboard Containers & BoxesFiscal year ends December 31
DSS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58−0.03 (-4.89%)
Close on Oct 19, 2026
- Market cap
- $5.83M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4.3%
0M of 10M shares
Institutional holders
16
4 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $17.92K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Heng Fai Ambrose Chan | 26,311,715 | 86.30% | 13D (active) amendment | Sep 3, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DSS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 208,481 | 2.08% | $123 | New | 0.00% |
| Vanguard Capital Management LLC | 58,032 | 0.58% | $34.24K | – | 0.00% |
| UBS Group AG | 55,558 | 0.55% | $32.78K | +55,077 | 0.00% |
| Geode Capital Management, LLC | 27,892 | 0.28% | $16.46K | −26,459 | 0.00% |
| Renaissance Technologies LLC | 27,048 | 0.27% | $15.96K | −10,194 | 0.00% |
| BlackRock, Inc. | 20,977 | 0.21% | $12.38K | – | 0.00% |
| XTX Topco Ltd | 14,323 | 0.14% | $8.45K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 7,527 | 0.07% | $4.44K | +2,361 | 0.00% |
| Vanguard Fiduciary Trust Co | 6,802 | 0.07% | $4.01K | – | 0.00% |
| Wells Fargo & Company/Mn | 157 | 0.00% | $93 | – | 0.00% |
| FMR LLC | 8 | 0.00% | $5 | New | 0.00% |
| SBI Securities Co., Ltd. | 2 | 0.00% | $1 | – | 0.00% |
| Danske Bank A/S | 2 | 0.00% | $1 | – | 0.00% |
| Union Bancaire Privee, UBP SA | 1 | 0.00% | $0 | – | 0.00% |
| Ronald Blue Trust, Inc. | 1 | 0.00% | $1 | New | 0.00% |
| Center for Financial Planning, Inc. | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 16 | 0M | 4.3% | 4 / 2 | 2 / 4 | 0M | 0M |
| Q1 2026 | 17 | 0M | 2.2% | 5 / 4 | 1 / 3 | 0M | 0M |
| Q4 2025 | 16 | 0M | 1.6% | 3 / 2 | 2 / 1 | 0M | 0M |
| Q3 2025 | 14 | 0M | 1.5% | 2 / 4 | 2 / 5 | 0M | 0M |
| Q2 2025 | 17 | 0M | 1.6% | 4 / 2 | 3 / 0 | 0M | 0M |
| Q1 2025 | 13 | 0M | 1.6% | 1 / 2 | 3 / 1 | 0M | 0M |
| Q4 2024 | 13 | 0M | 1.2% | 1 / 2 | 4 / 0 | 0M | 0M |
| Q3 2024 | 12 | 0M | 1.7% | 3 / 2 | 4 / 4 | 0M | 0M |
| Q2 2024 | 15 | 0M | 1.8% | 2 / 5 | 5 / 2 | 0M | 0M |
| Q1 2024 | 15 | 0M | 1.6% | 15 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of DSS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 58,032 | 0.58% | $34.24K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 46,271 | 0.46% | $22.21K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 5,454 | 0.05% | $2.62K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,202 | 0.01% | $577 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Heng Fai Ambrose Chan | Director, 10% owner | 2,034,922 | 20.26% | Sep 8, 2026 |
| International Ltd Alset | 10% owner | 102,766,013 | 1023.31% | Jul 9, 2026 |
| Inc. Alset | 10% owner | 19,888,262 | 198.04% | Jul 9, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Heng Fai Ambrose Chan Director, 10% owner | Sep 3, 2026 | Sale | −21,852 | $0.82 | $17.92K | 1,031,944 |
| Heng Fai Ambrose Chan Director, 10% owner | Aug 28, 2025 | Sale | +130,679 | $1.35 | $176.42K | 1,053,796 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 6, 2025 | Award | +1,000,000 | – | – | 1,002,978 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 10, 2024 | Buy | +820,597 | $0.97 | $795.98K | 3,961,211 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 10, 2024 | Buy | +205,149 | $0.97 | $198.99K | 1,184,475 |
| William Wai Leung Wu Director | Dec 29, 2023 | Sale | −150,000 | $0.13 | $19.50K | 0 |
| William Wai Leung Wu Director | Dec 29, 2023 | Sale | −1,020 | $0.13 | $133 | 0 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 28, 2023 | Buy | +672,173 | $0.15 | $100.83K | 19,586,499 |
| Frank D. Heuszel Chief Executive Officer, Director | Apr 10, 2023 | Award | +1,247,078 | $0.22 | $274.36K | 1,312,776 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 13, 2022 | Buy | +334,921 | $0.23 | $77.03K | 18,914,326 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 9, 2022 | Buy | +51,385 | $0.19 | $9.76K | 18,579,405 |
| International Ltd Alset 10% owner | Jul 12, 2022 | Other | +21,366,177 | – | – | 81,399,836 |
| Heng Fai Ambrose Chan Director, 10% owner | Jul 7, 2022 | Buy | +17,570,948 | – | – | 60,033,659 |
| William Wai Leung Wu Director | Jun 17, 2022 | Buy | +5,000 | $0.38 | $1.90K | 151,020 |
| William Wai Leung Wu Director | Jun 16, 2022 | Buy | +5,000 | $0.38 | $1.90K | 146,020 |
| William Wai Leung Wu Director | Jun 10, 2022 | Buy | +27,000 | $0.41 | $11.07K | 140,000 |
| William Wai Leung Wu Director | Jun 9, 2022 | Buy | +72,600 | $0.42 | $30.49K | 113,000 |
| William Wai Leung Wu Director | Jun 8, 2022 | Buy | +23,651 | $0.41 | $9.70K | 40,400 |
| William Wai Leung Wu Director | Jun 7, 2022 | Buy | +16,749 | $0.39 | $6.53K | 16,749 |
| Heng Fai Ambrose Chan Director, 10% owner | May 25, 2022 | Award | +15,389,995 | – | – | 16,973,020 |
| Frank D. Heuszel Chief Executive Officer, Director | May 4, 2022 | Award | +63,205 | $0.45 | $28.44K | 65,698 |
| Heng Fai Ambrose Chan Director, 10% owner | Apr 1, 2022 | Award | +894,084 | – | – | 1,583,025 |
| Heng Fai Ambrose Chan Director, 10% owner | Mar 9, 2022 | Buy | +3,986,877 | $0.38 | $1.52M | 26,178,632 |
| Heng Fai Ambrose Chan Director, 10% owner | Sep 8, 2021 | Buy | +12,155,591 | $1.23 | $14.95M | 22,191,755 |
| BioMedical Pte. Ltd. Global 10% owner | Jun 21, 2021 | Conversion | +1,120,170 | – | – | 10,036,164 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 16, 2021 | Buy | +555,000 | $1.70 | $943.50K | 8,947,012 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 15, 2021 | Buy | +115,960 | $1.77 | $205.25K | 7,507,972 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 15, 2021 | Buy | +884,040 | $1.69 | $1.49M | 8,392,012 |
| Heng Fai Ambrose Chan Director, 10% owner | May 26, 2021 | Conversion | +5,450,000 | – | – | 6,595,834 |
| BioMedical Pte. Ltd. Global 10% owner | Oct 16, 2020 | Conversion | +662,500 | – | – | 1,145,834 |
| Heng Fai Ambrose Chan Director, 10% owner | Aug 21, 2020 | Other | +483,334 | $6.48 | $3.13M | 483,334 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 24, 2020 | Award | +11,111,112 | $0.18 | $2.00M | 13,538,711 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 24, 2020 | Award | +11,111,111 | $0.18 | $2.00M | 13,538,710 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 18, 2020 | Award | +349,917 | – | – | 2,427,599 |
| Heng Fai Ambrose Chan Director, 10% owner | Nov 1, 2019 | Buy | +6,000,000 | $0.30 | $1.80M | 6,446,428 |
| Wah Wai Lo Director | Jul 23, 2019 | Award | +40,767 | – | – | 40,767 |
| John Thatch Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Jason Grady Chief Operating Officer | Jul 23, 2019 | Award | +74,770 | – | – | 74,770 |
| Joseph L. Sanders Director | Jul 23, 2019 | Award | +30,575 | – | – | 684,970 |
| Stanley V. Grisham Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Frank D. Heuszel Chief Executive Officer, Director | Jul 23, 2019 | Award | +74,770 | – | – | 74,770 |
| Heng Fai Ambrose Chan Director, 10% owner | Jul 23, 2019 | Award | +74,770 | – | – | 2,077,682 |
| Daniel DelGiorno Director | Jul 23, 2019 | Award | +40,767 | – | – | 40,767 |
| Pamela Avallone Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Brett L. Scott Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 10, 2019 | Buy | +2,000,000 | $0.50 | $1.00M | 2,002,912 |
| Joseph L. Sanders Director | Jun 6, 2019 | Buy | +1,181 | $0.48 | $567 | 654,395 |
| Joseph L. Sanders Director | May 20, 2019 | Buy | +3,181 | $1.05 | $3.34K | 653,214 |
| Heng Fai Ambrose Chan Director | Mar 25, 2019 | Conversion | +446,428 | $1.12 | $500.00K | 446,428 |
| Daniel DelGiorno Director | Mar 5, 2019 | Other | +130,435 | $1.15 | $150.00K | 130,435 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 17, 2018 | Buy | +612,245 | $0.98 | $600.00K | 1,786,531 |
| Heng Fai Ambrose Chan Director, 10% owner | Jul 3, 2018 | Buy | +214,286 | $1.40 | $300.00K | 1,174,286 |
| Joseph L. Sanders Director | Mar 30, 2018 | Buy | +400,000 | $0.75 | $300.00K | 650,033 |
| Jeffrey Ronaldi CEO, Director | Mar 21, 2018 | Award | +50,000 | – | – | 520,603 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 13, 2017 | Option exercise | +160,000 | $1.00 | $160.00K | 960,000 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 5, 2017 | Buy | +300 | $1.15 | $345 | 2,912 |
| Jeffrey Ronaldi CEO, Director | Nov 20, 2017 | Buy | +6,900 | $0.73 | $5.04K | 470,603 |
| Jeffrey Ronaldi CEO, Director | Nov 20, 2017 | Buy | +5,000 | $0.72 | $3.60K | 463,703 |
| Jeffrey Ronaldi CEO, Director | Nov 17, 2017 | Buy | +27,000 | $0.69 | $18.63K | 458,703 |
| Jeffrey Ronaldi CEO, Director | Nov 16, 2017 | Buy | +109,400 | $0.66 | $72.20K | 431,703 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Inc. Dss Stockholder | Apr 29, 2026 | 31,939,778 | $23.06M | Apr 22, 2026 | 31,939,778 were issued to DSS by the issuing company in full and final satisfaction of the Second Amended Promissory Note. |